INSIDER · CIK 1573785
Davidson Michael H.
Chief Executive Officer, Director at NewAmsterdam Pharma Co N.V. (NAMS)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$227KBought on the market
$0.00Sold on the market
1Companies
Sep 15, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202616:30 | Sep 14, 2026 | NAMSNewAmsterdam Pharma Co N.V. | Chief Executive Officer, Director | P · Buy | $22.65 | +10,000 | 792,923 | +1% | +$227K | -38.8% | -8.3% |